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The metabolic response to endotoxemia closely mimics those seen in sepsis. Here,
we show that the urinary excretion of the metabolite 2-hydroxyglutarate (2HG) is
dramatically suppressed following lipopolysaccharide (LPS) administration in vivo, and
in human septic patients. We further show that enhanced activation of the enzymes
responsible for 2-HG degradation, D- and L-2-HGDH, underlie this effect. To determine
the role of supplementation with 2HG, we carried out co-administration of LPS and
2HG. This co-administration in mice modulates a number of aspects of physiological
responses to LPS, and in particular, protects against LPS-induced hypothermia. Our
results identify a novel role for 2HG in endotoxemia pathophysiology, and suggest that
this metabolite may be a critical diagnostic and therapeutic target for sepsis.
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INTRODUCTION
Sepsis is defined as the dysregulated host response to infection (Singer et al., 2016) and is a major
cause of morbidity and mortality worldwide. The number of cases seen continues to increase, in
part due to a rise in the number of pathogens with antimicrobial resistance (AMR). However,
therapeutic and diagnostic options remain limited. Therefore, there is an urgent need to understand
its pathophysiology to develop novel diagnostic and therapeutic strategies.
In a healthy individual metabolism is characterized by synchronized anabolic and catabolic
processes which act to maintain cell homeostasis. However, in septic patients, intense metabolic
dysfunction occurs; contributing to sepsis pathophysiology and its sequelae of organ failure
(Chioléro et al., 1997). In recent years, metabolic profiling has been explored as a novel means to
approach diagnosis, prognosis and monitoring of septic patients (Seymour et al., 2013; Su et al.,
2014; Nguyen et al., 2015). Administration of the bacterial endotoxin, lipopolysaccharide (LPS,
the outer component of gram-negative bacteria), replicates the physiology and metabolic changes
seen in sepsis (Kamisoglu et al., 2015). Indeed, a previous study showed concordance in plasma
metabolomes between LPS-treated subjects and septic patients (Kamisoglu et al., 2015). Thus the
endotoxemia model is a relevant physiological model of sepsis, which also provides important
insights into the metabolic changes associated with sepsis.
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2-Hydroxyglutarate (2HG), a key metabolite of the
butanoate metabolic pathway, is produced by phosphoglycerate
dehydrogenase catalyzing the NADH-dependent reduction
of α-ketoglutarate (αKG) to 2HG (Nadtochiy et al., 2016).
In humans two enantiomers exist, R- and S-2HG, which are
normal endogenous metabolites present in all body fluids.
The R-enantiomer has also been shown to be generated by
gain-of-function mutations in the isocitrate dehydrogenase
isoforms, which are associated with numerous types of cancer
(Dang et al., 2009; Gross et al., 2010; Komotar et al., 2010). The
S-enantiomer has been demonstrated to be produced under
hypoxic conditions by lactate dehydrogenase (Intlekofer et al.,
2015) and malate dehydrogenase (Oldham et al., 2015) and
by lactate dehydrogenase in the testis (Teng et al., 2016). In
addition to its regulation by synthesis, the enzymes L- or D-2HG
dehydrogenase (L- or D-2HGDG) normally keep the level of
2HG low by promoting its conversion back to αKG (Nadtochiy
et al., 2016). Mutations in these enzymes produce the inherited
metabolic disease hydroxyglutaric acidosis (Nadtochiy et al.,
2016). More recently, the physiological role of 2HG has begun
to be elucidated. S-2HG has been shown to play a critical role as
an immunometabolite in shaping the T-cell response (Tyrakis
et al., 2016), while R-2HG has also been implicated in shaping
the immune response (Böttcher et al., 2018). Thus, 2HG may
have an important role in inflammatory and immunological
pathophysiology.
To date, the majority of studies have focused on the
tumor promoting roles of 2HG, but its contribution to the
pathophysiology of other disease states, including sepsis, remains
to be elucidated. In this study, using both murine models of
LPS-induced endotoxemia, and samples from human septic
patients, we investigated the changes in 2HG metabolism. We
subsequently determined the therapeutic potential of 2HG and
the mechanism underlying our observations.
MATERIALS AND METHODS
Wild-Type Mices
All procedures involving mice were approved by the University
of Cambridge, Animal Ethics Committee. Wild type male mice
in a C57/Bl6 background were purchased from Charles Rivers. fr.
Mice between 8 and 12 weeks were used for experiments. Urine
was obtained prior to the start of the experiments. Mice were
then intraperitoneally (i.p) administered 15 mg/kg of ultrapure
LPS (Fitzpatrick et al., 2018) (InvivoGen) and/or 50 mg/kg of
S-2HG (Tyrakis et al., 2016), IL-4 (20 mg/kg) or IFNgamma
(20 mg/kg) (R&D, United Kingdom). Mice were culled at the end
of the experimental protocol. Urine was collected at various times
post i.p. Urine was collected without intervention as previously
outlined (Kurien et al., 2004).
Transgenic Mice
HIF-1DF/LysM-Cre male transgenic mice in C57BL/6
background were generated as previously described (Takeda
et al., 2010). Cre-negative homozygous male littermates for the
conditional alleles were used as controls. Animals were between
8 and 10 weeks at the time of experiments. Urine was obtained
prior to the start of the experiment and mice were subsequently
administered LPS (15 mg/kg) i.p.
Cell Culture
Bone marrow derived macrophages (BMDM) were isolated
from the femurs and tibias obtained from male C57/Bl6 wild
type mice (8–10 weeks old) as previously described (Takeda
et al., 2010). Briefly, cells were plated in DMEM supplemented
with 10% heat inactivated FBS and 30% conditioned media
(supernatant from M-CSF expressing L929 cells). Adherent
BMDM were harvasted using 0.05% Trypsin EDTA after 7 days
in culture. Ultrapure LPS was obtained from Invitrogen and
R/S 2HG Octyl Ester Sodium salt were obtained from Toronto
Research Canada.
Human Critical Illness Samples
This study was undertaken in a group of patients that had
previously been included in an observational study of the
impact of critical illness on muscle function (16). Patients
were those enrolled in the previously described MUSCLE study
(NCT011063001). Ethical approval was obtained from University
College London Ethics Committee A. At enrollment, written
assent was obtained from the next-of-kin with retrospective
patient consent obtained when full mental capacity was regained.
During this study, urine samples were collected at inclusion
(ICU admission) from urinary catheters and on study days 3,
7, and 10 in patients expected to spend longer than 3 days in
the ICU. Urine samples were stored in aliquots at −80◦C until
analysis.
R-2HG Colorimetric Assay
Media was obtained from BMDM’s treated with LPS for 4 h.
Urine was obtained from mice before and at various times after
LPS (i.p) and serum was obtained from septic patients. All
samples were frozen at -80.R-2HG levels were quantified using
a R-HG Colorimetric kit (Biovision, California, United States)
according to the manufacturer’s guidelines.
2-HG Mass Spectroscopy
Extraction of 2HG from lysed cell pellets and urine samples
was performed using methanol protein precipitation (containing
deuterated 2HG internal standard) followed by derivatization of
the enantiomers using Diacetyl-L-tartaric anhydride (DATAN).
LC-MS/MS analysis was performed using a Shimadzu Nexera
X2 UHPLC system coupled to a Sciex Triple Quad 6500 Mass
Spectrometer. Derivatized enantiomers of 2HG and internal
standard were separated on a Waters Acquity UPLC HSS T3,
100 × 2.1 mm, 1.8 µm column using a 125 mg/L Ammonium
Formate (aq) pH3.6/Acetonitrile gradient.
Radiotelemetry Measurements
Radio-transmitters (DSI, United States) were surgically
implanted into wild type mice weighing >25 g, under
1www.clinicaltrials.gov
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anesthesia as previously described (Fitzpatrick et al., 2018).
10 days post-surgery the transmitters were turned on and
baseline temperature, blood pressure and heart rate recordings
were obtained. LPS (15 mg/kg) and 2HG (50 mg/kg) i.p were
administered under anesthesia. Once mice had recovered
from the anesthetic, additional recordings were obtained
for a further 6 h.
Real-Time PCR (RT-PCR)
Total RNA was isolated using an UltaClean Tissue and Cell
RNA isolation kit (Mobio, Canada). cDNA was synthesized
from 1 ug of total RNA using Superscript III (Invitrogen,
United Kingdom) according to the manufacturers protocol.
Relative abundance of transcripts were assessed by Q-PCR
following normalization to B2M or 18S. QuantiTect Primer
Assays (Qiagen, United Kingdom) were obtained for
all transcripts.
Immunoblotting
Protein was isolated using RIPA buffer and normalized using
a Bradford assay. Ten micrograms of whole cell protein
were separated on 4–8% Tris-acetate gels (Invitrogen,
United Kingdom) followed by immunoblotting. Primary
antibodies for L2HGDG, D2HGDG, Bactin (Thermo Fisher,
United Kingdom), HIF-1α and iNOS (Novus, United Kingdom)
were subsequently probed with secondary antibodies from
Amersham and visualized using ECL plus (GE Healthcare,
United Kingdom).
Arginase Activity Assay
Following treatment BMDM were lysed in an arginase lyses
buffer as previously described (Puthucheary et al., 2013). 50 uL
of lysate was incubated with 75 uL of Tris–HCl (50 mmol/L,
pH 7.5) containing 10 mmol/L MnCl2. The lysate was heated
to 55◦C for 10 min to activate the arginase. The hydrolysis
reaction of L-arginine by arginase was performed by incubating
the mixture containing activated arginase with 50 uL of
L-arginine (0.5 mol/L, pH 9.7) at 37◦C for 1 h. The reaction
was subsequently stopped by adding 400 uL of the acid
solution mixture (H2SO4:H3PO4:H2O1:3:7). For colorimetric
determination of urea, -isonitrosopropiophenone (25 uL, 9% in
absolute ethanol) was added and the mixture was incubated at
100◦C for 45 min. After placing the sample in the dark for 10 min
at room temperature, the urea concentration was determined
spectrophotometrically by the absorbance at 550 nm measured
with a microplate reader (BioTek Instruments). The amount of
urea produced, after normalization with protein, was used as an
index for arginase activity.
Extracellular Flux Analysis
Bone marrow derived macrophages were seeded at a density of
70,000 cells per well 24 h prior to the assay. Following a media
change cells were left untreated or treated with LPS alone, S-
2HG or LPS + S-2HG for 4 h. OCR were measured on an XFe24
Analyzer (Seahorse Bioscience). The mitochondrial stress test was
performed according to the manufacturer’s protocol.
Statistical Analysis
All statistical analysis was performed using Prism (Graphpad
software). If not otherwise stated, a two-sided unpaired Students
t-test or ANOVA was used to analyze the differences in means
between the treatment groups.
RESULTS
Urinary Excretion of 2HG Is Suppressed
in Sepsis
We began by investigating the impact of LPS stimulation on
the urinary excretion of 2-HG, in wild type C57/Bl6 mice.
Urine was obtained from mice prior to and at various time
points post LPS (15 mg/kg I.p.) administration. An initial
increase in R-2HG excretion after 30 min (p < 0.05), was
followed by a significant suppression in urinary excretion
by 4 h (p < 0.05) (Figure 1A). We subsequently utilized
mass spectroscopy to quantify both R- and S-2HG urinary
concentrations. In agreement, with the previous experiment
a significant elevation in urinary R-2HG excretion occurred
after 30 min and loss of excretion by 4 h (Figure 1B).
Furthermore, a similar effect was also observed on S-2HG
excretion (Figure 1C). However, neither R- or S-2HG urinary
excretion was significantly altered by the administration of
the cytokines IL- 4 (Supplementary Figure S1) or IFNgamma
(Supplementary Figure S2). Administration of LPS in vivo
replicates the physiology of sepsis. Thus, we determined the
effect of sepsis on urinary R-2HG excretion in ICU patients.
A colorimetric assay for R-2HG, showed that R-2HG excretion
could be used to distinguish patients with sepsis from those with
trauma (Figure 1D). Furthermore, serum levels of R-2HG was
reduced in serum isolated from septic patients (Figure 1E). LPS
induces significant changes in innate immune cells. We next
investigate the effect of LPS stimulation on BMDM. A significant
increase in both R- and S-2HG was observed following LPS
stimulation (Figure 1F).
LPS Promotes 2HG Degradation Through
a HIF-1/2HGDG Pathway
We subsequently investigated the mechanism responsible for
reduced urinary excretion of 2HG. 2HGDG is a mitochondrial
enzyme responsible for the conversion of 2HG to α ketoglutarate
(αKG). To assess whether LPS altered 2HGDG activation, protein
was obtained from BMDM treated with LPS. A significant
increase in the protein expression of L-2HGDH was observed
4 h after LPS stimulation, while D-2HGDH was found to be
initially suppressed and increased at 4 h (Figure 1G). HIF-1α has
been shown to modulate 2HGDH and thus 2HG. In urine taken
from HIF-1DF/LysM mice a significant protective effect on R-
2HG but not S-2HG excretion was observed in comparison to the
HIF-1DF controls following 6 h of LPS treatment (Figure 1H).
These, results propose that the LPS induced activation of 2HGDG
promotes the breakdown of 2HG, which may in part account for
its reduced urinary excretion.
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FIGURE 1 | Urinary excretion of 2-HG is suppressed in sepsis. Mice were treated with LPS (15 mg/kg) and urine was obtained over a time course 0–4 h. Urine
samples were subsequently measured using a (A) colorimetric assay for R-2HG or mass spectroscopy for (B) R- and (C) S-2HG. N ≥ 7 for all time points. R-2HG
levels was quantified in (D) urine or (E) serum isolated from septic patients. (F) R- and S-2HG were quantified by mass spectroscopy in BMDM treated with LPS
(1 ug/ml) (G) BMDM were treated with LPS (1 ug/ml). Immunoblotting for L/D-2HGDG protein was performed and quantified by densitometry analysis. N = 3.
(H) Urine was taken from wild type (HIF-1DF) and HIF-1DF/LysM mice at baseline. Following LPS (15 mg/kg) administration urine was obtained after 4 h and mass
spectroscopy for both R- and S-2HG was performed. N = 6–8 for all time points. * p < 0.05,. ** p < 0.01, *** p < 0.005, and **** p < 0.001.
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FIGURE 2 | 2-HG protects against LPS induced hypothermia. Mice were surgically implanted with a radiotelemetry probe. 10 days post-surgery (A) Baseline
temperature recordings were obtained. Mice were subsequently treated (B) S-2-HG (50 ug/kg) (C) LPS (15 mg/kg) or a combination of LPS and S-2HG and
temperature recordings were obtained for an additional 8 h. N = 4/5. * p < 0.05.
2-HG Protects Against LPS Induced
Hypothermia
To determine if 2HG could have a therapeutic effect on LPS
pathophysiology, we next investigated the impact of 2HG
administration on LPS-induced symptomology in vivo. LPS-
induced endotoxemia manifests as disruptions in heart rate,
blood pressure and body temperature. Wild-type mice were
surgically implanted with radiotelemetry probes. Ten days post-
surgery baseline temperature, heartrate and blood pressure
measurements were obtained for all treatment groups (Figure 2A
and Supplementary Figure S3). 2HG administration did not
affect LPS-induced tachycardia or hypotension (Supplementary
Figure S3). Interestingly, while S-2HG alone had no effect on
temperature (Figure 2B) co-administration of LPS and S-2HG
was found to have a significant protective effect against LPS-
induced hypothermia (Figure 2C).
2HG Protects Against LPS Driven HIF-1α
Stabilization
Inducible nitric oxide synthase (iNOS) plays an important
role in regulating hypothermia. Therefore, we investigated the
degree to which S-2HG mediated its protective effects on LPS-
induced hypothermia by regulating iNOS signaling. We observed
enhanced iNOS mRNA and protein levels in LPS-treated BMDM.
However, combined treatment with R- or S-2HG and LPS caused
a significant suppression of both iNOS mRNA (p < 0.001)
(Figure 3A) and protein expression (Figure 3B). Furthermore,
a significant increase in arginase activity was observed in cells
treated with S-2HG and LPS in comparison to LPS alone
(p < 0.0001) (Figure 3C). HIF-1α is a key regulator of iNOS,
in response to LPS (Takeda et al., 2010). Thus, we subsequently
investigated the effect of 2HG on HIF-1α expression. LPS-
stimulated up-regulation of HIF-1α mRNA expression was
unaffected by the presence of either R- or S-2HG (Figure 3D).
In contrast, the LPS-induced upregulation of HIF-1α protein
expression was suppressed when cells were co-treated with LPS
and R- or S-2HG (Figure 3E).
S-2HG Improves Mitochondrial
Respiration
Excessive NO production during sepsis results in mitochondrial
dysfunction. We next tested the hypothesis that S-2HG protects
against this. BMDM treated with a combination of S-2HG and
LPS had a significant improvement in both basal respiration and
maximal respiratory capacity in comparison to LPS or S-2HG
alone (Figure 3F).
DISCUSSION
The response to endotoxemia is closely associated with alterations
in metabolism, which closely mimic those seen in sepsis
(Kamisoglu et al., 2015). Using a mouse model of LPS-induced
endotoxemia, we showed that the temporal dynamics of the
urinary excretion of the metabolite 2HG is significantly altered
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FIGURE 3 | 2HG protects against LPS driven HIF-1α stabilization. BMDB were treated with 250 or 500 uM R-/S-2HG in the presence or absence of LPS. 24 h
post-stimulation (A) iNOS RNA expression was quantified by RT-PCR, (B) iNOS protein expression was determined by immunoblotting (C) Arginase activity was
measured using a urea production assay. (D) HIF-1αmRNA was measured by RT-PCR (E) HIF-1α protein expression was measure by western blot analysis
(F) BMDM were treat with LPS for 4 h and a Seahorse Mitochondrial Stress Test was carried out. N = 3–5 for all experiments. * p < 0.05, *** p < 0.005, ****
p < 0.001.(G) Schematic of the role of 2HG in endotoxemia induced hypothermia.
in response to endotoxemia. This is consistent with previous
studies, which have shown that the dynamics of metabolic
pathways and metabolites (e.g. glucose, amino acids, and lipids)
are significantly altered in response to LPS and sepsis (Kamisoglu
et al., 2013, 2015; Terenina et al., 2017; Fitzpatrick et al., 2018).
Moreover, in septic patients 2HG levels were also reduced in both
urine and serum samples. Recently, the use of urinary 2HG as
a biomarker has been proposed for the identification of IDH-
mutant gliomas and to predict an ulcerative colitis patients risk of
developing colon cancer (Han et al., 2018). While further clinical
studies are required our results suggest 2HG may have a potential
role as a predictive biomarker for sepsis.
The molecular mechanisms governing the regulation of
2HG under physiological and pathophysiological conditions
remain poorly understood. 2HG is produced from αKG
(Nadtochiy et al., 2016), glutamine (Oldham et al., 2015), glucose
(Teng et al., 2016), lactate dehydrogenase (Intlekofer et al., 2015;
Teng et al., 2016), and malate dehydrogenase (Oldham et al.,
2015). Endotoxemia and sepsis are associated with profound
changes in numerous metabolic pathways including glycolytic,
tricylic-acid cycle (TCA), glutamine and arginine metabolism
(reviewed Fitzpatrick, 2019). Thus we hypothesis that the
changes in the temporal dynamics of 2HG are a consequence
of metabolic dysregulation. Consistent with this idea, in hypoxia
TCA dysfunction leads to L-2HG accumulation (Oldham et al.,
2015). Point mutations in the 2HGDH enzymes also lead to the
accumulation of 2HG and studies in drosophila, have reported
that metabolic products are key regulators of L2HGDH (Li et al.,
2018). We reasoned that endotoxemia induced changes in 2HG
maybe a consequence of altered 2HGDH levels. Suppressed 2-
HG excretion correlated with an increase in the expression of
2HGDG. It has recently been shown that HIF-1α expression
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is directly proportional to D2HGDH, and that HIF-1α can
modulate 2HG levels by binding directly to the D2HGDH
promoter (Han et al., 2018). Consistent, with these studies we
observed increased urinary 2HG levels following loss of HIF-1α.
We propose that 2HG is suppressed in part due to the activation
of a HIF-1α/2HGDH signaling pathway (Figure 3G).
The enantiomers of 2HG serve as important regulators of
cellular redox homeostasis, cellular energy metabolism and the
immune system (Oldham et al., 2015; Böttcher et al., 2018).
Consequently, temporal changes in 2HG, in septic patients, will
likely have a significant impact upon these processes, which
in turn will contribute to clinical symptomology. We observed
that S-2HG administration had a significant protective effect
against LPS induced hypothermia. The etiology of hypothermia
during sepsis is poorly understood. However, it has been
shown to be related to mitochondrial dysfunction due to
excessive nitric oxide production from iNOS (Saia and Carnio,
2006; Hiller et al., 2014). Our results demonstrated that S-
2HG protects against NO generation. We believe that this is
due in part to a protective effect of S-2HG on mitochondria
function and an increase in mitochondrial antioxidant capacity.
Consistent with this idea, studies have demonstrated that S-
2HG application increases mitochondrial respiration (Böttcher
et al., 2018), while in hypoxia R-2HG accumulation regulates
cellular redox homeostasis by controlling bioenergetic pathways
(Oldham et al., 2015). Furthermore, in LPS stimulated BMDM
treated with S-2HG we observed a significant improvement in
mitochondrial function.
An increasing number of studies have identified that
mitochondrial dysfunction contributes to epigenetic
modification (reviewed Minocherhomji et al., 2012). Thus,
given the literature showing 2HG as an epigenetic modifier,
it is reasonable to predict that S-2HG may cause epigenetic
modification of the iNOS promoter, leading to its suppressed
activity (Rigillo et al., 2018). Inhibition of 2-oxoglutarate-
dependent dioxygenases, that demethylate histones (Jumonji
C containing proteins) or oxidize 5-methylcytosine in DNA
(Ten-eleven translocation (Tet) proteins) could mediate S-
2HG’s effect. Indeed, in CD8+ T cells S-2HG induces global
methylation changes and small changes in 5-methylcytosine
(Tyrakis et al., 2016).
In addition, to its effects at suppressing oxidative signaling,
S-2HG could also promote anti-oxidative pathways. Nuclear
factor-eythroid 2-related factor (Nrf2), a key transcription factor
involved in activation of antioxidative and cytoprotective genes,
is activated by DNA demethylation and histone methylation
(Kang and Hyun, 2017). Furthermore, Nrf2 is also a key regulator
of metabolism and mice with constitutive Nrf2 improved
mitochondrial function, as demonstrated by higher OCR levels
(Ohl et al., 2018). This is consistent with the increased OCR we
observed in LPS-stimulated BMDM’s treated with S-2HG. Future
studies will focus on understanding the interact between 2HG,
redox homeostasis and epigenetics in sepsis models.
HIF-1α, the master regulator of the hypoxia response,
plays a vital role in iNOS activation (Takeda et al., 2010).
Moreover, previous studies have demonstrated that loss of HIF-
1α signaling protects against endotoxemia and sepsis-induced
hypothermia (Peyssonnaux et al., 2007; Mahabeleshwar et al.,
2011; Fitzpatrick et al., 2018). Indeed, we observed HIF-1α
protein destabilization upon S-2HG treatment. Earlier studies
have shown that 2HG accumulation negatively impacts HIF-
1α stability, an effect due in part to enhanced proteasomal
degradation by the prolyl hydroxylase enzymes (Intlekofer et al.,
2015). Thus, suppressed HIF-1α signaling could contribute to
the decreased iNOS signaling and subsequent normothermia
following S-2HG treatment (Figure 3G).
In summary, our results have identified a novel role for 2HG in
endotoxemia and show that S-2HG protects against endotoxemia
induced hypothermia. Cellular metabolism and oxidative stress
are intimately linked. S-2HG through epigenetic modification
may suppress oxidative signaling, while enhancing antioxidative
signaling, which in turn could have a protective effect on
endotoxemia-induced hypothermia. Determining the detailed
signaling mechanism involved will identify novel therapeutic
targets for sepsis treatment.
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FIGURE S1 | Mice were treated with IL-4 (20 mg/kg) and urine was obtained over
a time course 0–4 h. Urine samples were subsequently measured by mass
spectroscopy for both R- and S-2HG. N = 4 or more.
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FIGURE S2 | Mice were treated with IFNgamma (20 mg/kg) and urine
was obtained over a time course 0–4 h. Urine samples were subsequently
measured by mass spectroscopy for both R- and S-2HG. N = 4
or more.
FIGURE S3 | Following radiotelemetry implantation baseline measurements were
obtained for systolic and diastolic blood pressure, and heart rate. Mice were
subsequently treated with LPS (15 mg/kg) or a combination of LPS and S-2HG
(50 ug/kg) and recordings were obtained for an additional 8 h. N = 4/5.
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